TOBI is a Oral Solution in the Human Prescription Drug category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is Tobramycin.
| Product ID | 0078-0494_cb71e4dc-f6a7-455f-b72c-78cb8a4d3fee |
| NDC | 0078-0494 |
| Product Type | Human Prescription Drug |
| Proprietary Name | TOBI |
| Generic Name | Tobramycin |
| Dosage Form | Solution |
| Route of Administration | ORAL |
| Marketing Start Date | 1997-12-22 |
| Marketing Category | NDA / NDA |
| Application Number | NDA050753 |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Substance Name | TOBRAMYCIN |
| Active Ingredient Strength | 300 mg/5mL |
| Pharm Classes | Aminoglycoside Antibacterial [EPC],Aminoglycosides [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 1997-12-22 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA050753 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2014-07-02 |
| Marketing Category | NDA |
| Application Number | NDA050753 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 1997-12-22 |
| Marketing Category | NDA |
| Application Number | NDA050753 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 1997-12-22 |
| Ingredient | Strength |
|---|---|
| TOBRAMYCIN | 300 mg/5mL |
| SPL SET ID: | 94f9e516-6bf6-4e30-8dde-8833c25c2560 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0078-0494 | TOBI | Tobramycin |
| 10122-820 | BETHKIS | tobramycin |
| 0078-0630 | TOBI Podhaler | Tobramycin |
| 0093-3750 | Tobramycin | Tobramycin |
| 0093-4085 | Tobramycin | Tobramycin |
| 0404-7196 | Tobramycin | Tobramycin |
| 0409-3578 | TOBRAMYCIN | TOBRAMYCIN |
| 0703-9402 | Tobramycin | Tobramycin |
| 0781-7171 | Tobramycin | Tobramycin |
| 10544-883 | Tobramycin | Tobramycin |
| 13985-604 | Tobramycin | Tobramycin |
| 13985-743 | Tobramycin | Tobramycin |
| 17478-290 | Tobramycin | Tobramycin |
| 17478-340 | Tobramycin | Tobramycin |
| 0065-0643 | Tobrex | tobramycin |
| 0065-0644 | TOBREX | tobramycin |
| 0078-0813 | TOBREX | tobramycin |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() TOBI 98829213 not registered Live/Pending |
Tobi, Inc. 2024-10-30 |
![]() TOBI 97669601 not registered Live/Pending |
SCSE HOME LLC 2022-11-09 |
![]() TOBI 90784685 not registered Live/Pending |
HCW Biologics, Inc. 2021-06-21 |
![]() TOBI 90123270 not registered Live/Pending |
Wei, Chao 2020-08-19 |
![]() TOBI 88847929 not registered Live/Pending |
MGA Entertainment, Inc. 2020-03-25 |
![]() TOBI 85931463 not registered Dead/Abandoned |
Novartis AG 2013-05-14 |
![]() TOBI 85746006 4983442 Live/Registered |
Little Airplane Productions, Inc. 2012-10-04 |
![]() TOBI 85170184 4028028 Dead/Cancelled |
The Oncology Business Institute 2010-11-05 |
![]() TOBI 85145153 4488766 Live/Registered |
BGP PRODUCTS OPERATIONS GMBH 2010-10-05 |
![]() TOBI 79352748 not registered Live/Pending |
Nicole Bongartz 2022-09-16 |
![]() TOBI 78857304 3280946 Live/Registered |
TOBI PRODUCTS, INC. 2006-04-09 |
![]() TOBI 78434648 3406527 Live/Registered |
Tobi, LLC 2004-06-14 |